The following section provides information on Clinuvel Pharmaceuticals Ltd’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Clinuvel Pharmaceuticals Ltd's management and employees, unlock the full data with our company analytics monitoring tool.
Dr. Phillipe J. Wolgen has been the Chief Executive Officer, the Managing Director and Director of Clinuvel Pharmaceuticals Ltd since 2005. He has experience in international finance and contacts to European capital markets with an exporsure to equity research in the bio-medical industry. Previously, Dr. Wolgen also held positions in private pharmaceutical companies in Europe, the UK and Israel. He been recognized for his strategic mindset and meticulous execution in business. He is also a board-member and founder of WOKO Indonesia.
Mr. Darren M. Keamy has been the chief financial officer and the secretary of Clinuvel Pharmaceuticals Limited since 2006. Prior to this, he served in key management accounting and commercial roles at Amcor Limited for over 9 years. He worked for two years in the UK and gained financial experience.
Dr. Dennis Wright serves as the Chief Scientific Officer of the company. Prior to this, he served in leadership roles including Regulatory Affairs Manager at CSL and Global Pharmacovigilance Manager and Regulatory Affairs Manager of Mayne Pharma.
Mr. Willem Blijdorp has been the Chairman of the company since November 2019. Previously, he served as a Director of the company. Previously, he served as the Chief Executive Officer of B&S Group.
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer